Strate Labs Closure Notice Remains Online as Separate Domain Displays Research Catalog
MIAMI, FL —(SP Tech Solutions)— October 13, 2026 — A review of two websites using the Strate Labs name found that the former domain, stratelabs.com, continues to display a permanent closure notice, while strateslab.com presents a research-products catalog and published ordering policies. The available information does not independently establish whether the two websites are operated by the same legal entity.
The distinction is relevant to customers searching for information about the Strate Labs shutdown in 2026, including the reported closure timeline, the current storefront, and the handling of earlier orders.
Former Strate Labs Website Reports Permanent Closure
The closure notice on stratelabs.com attributes the former business's decision to changes in the regulatory environment. It also refers visitors to Chemistry Works and GL Peptides, expressly describing those businesses as independent and unaffiliated with Strate Labs.
The notice does not identify strateslab.com as a replacement website, announce a transfer of the former business, or specify a confirmed final trading date.
A Peptide Supply article published on June 8, 2026, reported a planned July 1 shutdown and associated clearance pricing. That report documents the announced timetable but does not independently establish the precise date on which the former business ceased accepting or fulfilling orders.
Regulatory Background and the 2026 Shutdown
A separate U.S. International Trade Commission record provides relevant regulatory context. A Federal Register notice dated April 15, 2025, identifies Strate Labs LLC of Spring, Texas, among the respondents in a proceeding involving certain products containing or purporting to contain tirzepatide. The notice records a default finding and announces exclusion remedies and a cease-and-desist order.
The proceeding predates the reported 2026 shutdown. However, the available record does not establish that it was the sole cause of the closure. Its findings should not be generalized to every product currently listed on strateslab.com.
Current Activity at Strateslab.com
As reviewed on October 11, 2026, strateslab.com displayed research-product categories, product specifications, testing information, and ordering policies. Its catalog includes listings for research peptides such as GHK-Cu and BPC-157, as well as SARMs listings such as RAD-140.
The current operator reports that the business has resumed operations and that several customers have placed orders and received packages. These delivery accounts have not been independently verified for this review.
The current website also describes its testing procedures, fulfillment arrangements, and return terms. These are statements published by the supplier and should be distinguished from independently verified laboratory results or guarantees of delivery. Buyers should confirm the relevant batch documentation, current terms, and shipping arrangements directly with the seller.
The website states that its products are intended for laboratory research use only and are not intended for human consumption or medical or veterinary use. Their inclusion in an online catalog does not establish approval as medicines.
Questions About Earlier Orders Remain Unresolved
Customers with outstanding orders or account issues involving the former Strate Labs website should retain their original invoices, payment records, order confirmations, and correspondence.
The existence of a separate catalog at strateslab.com does not, by itself, establish that the current operator has assumed responsibility for earlier transactions, refund obligations, customer accounts, or pending orders.
A public statement identifying the current operating entity, confirming the reopening date, and explaining any relationship to the former business would help clarify these outstanding questions.
Current Status
As of October 11, 2026, the former Strate Labs domain continues to display its permanent closure notice, while strateslab.com presents an accessible research catalog and ordering information. The operator reports renewed activity, but the reopening timeline, corporate relationship between the domains, and continuity of earlier customer obligations remain unconfirmed by the information reviewed.
Media Contact
Website: https://strateslab.com/
Email: info@strateslab.com
City: Miami, Florida, USA
Editorial note: Source references should be converted into working links to the original closure notice, Peptide Supply report, Federal Register record, and current website pages before publication. The media contact details and dateline should also be confirmed with the issuing organization.